Bank of New York Mellon
VAXX

Bank of New York Mellon’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bank of New York Mellon’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,015
Closed -$78.9K – 4327
2024
Q1 		$78.9K Sell
110,015
-10,650
-9% -$7.72K ﹤0.01% 4053
2023
Q4 		$103K Sell
120,665
-857
-0.7% -$828 ﹤0.01% 4078
2023
Q3 		$166K Sell
121,522
-21,193
-15% -$45.9K ﹤0.01% 4006
2023
Q2 		$360K Buy
142,715
+107,919
+310% +$229K ﹤0.01% 3758
2023
Q1 		$79K Hold
34,796
– – ﹤0.01% 4112
2022
Q4 		$48.7K Buy
+34,796
New +$58.5K ﹤0.01% 4241

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Bank of New York Mellon's VAXX Position: Q2 2024 in Review

Bank of New York Mellon sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 110,015 shares — an estimated $78.9K sold.

Bank of New York Mellon first reported a position in VAXX in Q4 2022 and held it in 6 quarters. The position peaked at $360K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Bank of New York Mellon reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 110,015 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $78.9K.
  • Bank of New York Mellon first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2022 and held it in 6 quarters.
  • Bank of New York Mellon's Vaxxinity, Inc. Class A Common Stock position peaked at $360K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.